Genetic Influences in Breast Cancer Drug Resistance

Código QR

Genetic Influences in Breast Cancer Drug Resistance

Adhitiya Daniyal,1 Ivana Santoso,1 Nadira Hasna Putri Gunawan,1 Melisa Intan Barliana,2,3 Rizky Abdulah1,2 1Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Indonesia; 2Center of Excellence in Higher Education for Pharmaceutical Care Innovat...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Daniyal A, Santoso I, Gunawan NHP, Barliana MI, Abdulah R
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	breast cancer genetic polymorphisms resistance therapy Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/ae258ae209c54dc28b8954044802883a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Genetic polymorphism of GSTM1 in women with breast cancer and interact with reproductive history and several clinical pathologies
por: LINHARES,JOSÉ JUVENAL, et al.
Publicado: (2005)

Resistance and Overcoming Resistance in Breast Cancer
por: Luque-Bolivar A, et al.
Publicado: (2020)

Alternative therapies for metastatic breast cancer: multimodal approach targeting tumor cell heterogeneity
por: Sambi M, et al.
Publicado: (2017)

Awareness and current knowledge of breast cancer
por: Akram,Muhammad, et al.
Publicado: (2017)

Overview of the genetic basis toward early detection of breast cancer
por: De Silva S, et al.
Publicado: (2019)

Reduction in breast cancer susceptibility due to XbaI gene polymorphism of alpha estrogen receptor gene in Jordanians
por: Atoum MF, et al.
Publicado: (2017)

Extreme Oncoplasty: Breast Conservation in Patients with Large, Multifocal, and Multicentric Breast Cancer
por: Savioli F, et al.
Publicado: (2021)

Targeting stem cells in the realm of drug-resistant breast cancer
por: Dey P, et al.
Publicado: (2019)

Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women
por: Murillo-Ortiz B, et al.
Publicado: (2017)

Adjuvant systemic therapy in older women with breast cancer
por: Leone J, et al.
Publicado: (2016)

Does the Presence of Cytokeratin Positive Individual Tumor Cells (N0(I+)) in Sentinel Lymph Nodes Affect Clinical Outcomes in Breast Cancer Patients Treated with Accelerated Partial Breast Irradiation
por: Smith J, et al.
Publicado: (2021)

Opioids and Breast Cancer Recurrence: A Systematic Review
por: Merlino Lucia, et al.
Publicado: (2021)

Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance
por: Xupeng Bai, et al.
Publicado: (2021)

Assessment of changes in the brca2 and p53 genes in breast invasive ductal carcinoma in northeast Brazil
por: Ramalho,Eduardo AVF, et al.
Publicado: (2014)

A GM-CSF and CD40L bystander vaccine is effective in a murine breast cancer model
por: Soliman H, et al.
Publicado: (2015)

Comparison Of Accelerated Partial Breast Radiation Therapy And External Beam Radiation Therapy By Treatment Planning Indices
por: Hejazi P, et al.
Publicado: (2019)

Current advances in biomarkers for targeted therapy in triple-negative breast cancer
por: Fleisher B, et al.
Publicado: (2016)

Cytotoxicity of synthetic derivatives against breast cancer and multi-drug resistant breast cancer cell lines: a literature-based perspective study
por: Shabnam Sharmin, et al.
Publicado: (2021)

Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis
por: Delou JM, et al.
Publicado: (2017)

Hormone Therapy and Factors Affecting Fertility of Women Under 50-Year-Old with Breast Cancer
por: Moradinazar M, et al.
Publicado: (2019)

Antiangiogenic therapy for breast cancer with triple negative phenotype
por: Inna P. Ganshina, et al.
Publicado: (2021)

Patients’ characteristics, Cytochrome P4501A1 genetic polymorphisms and breast cancer risk in Sudanese women
por: Fatima Hamad, et al.
Publicado: (2021)

An Insight into the Role of Bee Venom and Melittin Against Tumor Cells: A Review of Breast Cancer therapy
por: Roha Tariq, et al.
Publicado: (2021)

MicroRNA-1246 Mediates Drug Resistance and Metastasis in Breast Cancer by Targeting NFE2L3
por: Yue-chu Dai, et al.
Publicado: (2021)

Single-Nucleotide Polymorphisms Promote Dysregulation Activation by Essential Gene Mediated Bio-Molecular Interaction in Breast Cancer
por: Xue Wang, et al.
Publicado: (2021)

TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer
por: Isabel Grote, et al.
Publicado: (2021)

Factors affecting local recurrence and distant metastases of invasive breast cancer after breast-conserving surgery in Chiang Mai University Hospital
por: Ditsatham C, et al.
Publicado: (2016)

First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study
por: Sonia Pernas, et al.
Publicado: (2021)

An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors
por: Koleck TA, et al.
Publicado: (2017)

Prospects of eribulin administration for patients with HR-positive HER2-negative metastatic breast cancer after progression on CDK4/6 Inhibitors: theoretical background and first experience
por: Irina V. Kolyadina, et al.
Publicado: (2020)

Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
por: Mai F. Tolba, et al.
Publicado: (2021)

Positive margins (R1) risk factors in breast cancer conservative surgery
por: Lombardi A, et al.
Publicado: (2019)

Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer Attending the Tikur Anbessa Specialized Hospital, Addis Ababa Ethiopia, 2019: A Cross-sectional Study
por: Wako Z, et al.
Publicado: (2021)

Dietary Factors and Breast Cancer Prognosis among Breast Cancer Survivors: A Systematic Review and Meta-Analysis of Cohort Studies
por: Sin-Hye Park, et al.
Publicado: (2021)

Associations between ADIPOQ rs2241766 SNP and breast cancer risk: a systematic review and a meta-analysis
por: Xue Hu, et al.
Publicado: (2021)

Novel therapeutic strategies for patients with metastatic triple-negative breast cancer
por: Inna P. Ganshina, et al.
Publicado: (2021)

Breast cancer
por: Liudmila G. Zhukova, et al.
Publicado: (2021)

A Retrospective Analysis of the Effect of Irinotecan-Based Regimens in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
por: Jiaojiao Suo, et al.
Publicado: (2021)

Association of p53 Arg/Pro Polymorphism at Codon 72 with Risk of Breast Cancer in East Azerbaijani Women
por: MA Hossein Pour Feizi, et al.
Publicado: (2012)

Resistance Mechanisms to Combined CDK4/6 Inhibitors and Endocrine Therapy in ER+/HER2− Advanced Breast Cancer: Biomarkers and Potential Novel Treatment Strategies
por: Abeer J. Al-Qasem, et al.
Publicado: (2021)